etoposide has been researched along with apatinib in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, YL; Huang, HQ; Huang, X; Lan, CY; Li, JD; Li, YF; Liu, Q; Shen, JX; Wang, Y; Xiong, Y; Zhang, YN; Zheng, M | 1 |
| Gourley, C | 1 |
| Di, Y; Kang, L; Qiu, G; Ren, C; Wang, Q; Zhao, J | 1 |
| Ni, J; Si, X; Wang, H; Zhang, L; Zhang, X | 1 |
| Cai, L; Cao, M; Chen, X; Chen, Y; He, T; Hu, J; Huang, J; Li, C; Liu, W; Liu, X; Lu, H; Pang, H; Sun, L; Sun, Y; Xing, Y; Yan, S; Zhang, N; Zhao, D; Zhao, L | 1 |
3 trial(s) available for etoposide and apatinib
| Article | Year |
|---|---|
Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Platinum Compounds; Progression-Free Survival; Prospective Studies; Pyridines; Time Factors; Young Adult | 2018 |
Camrelizumab plus platinum-irinotecan followed by maintenance camrelizumab plus apatinib in untreated extensive-stage small-cell lung cancer: a nonrandomized clinical trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Immune Checkpoint Inhibitors; Irinotecan; Lung Neoplasms; Platinum | 2023 |
Apatinib plus etoposide in pretreated patients with advanced triple-negative breast cancer: a phase II trial.
Topics: Antineoplastic Agents; Etoposide; Humans; Hypertension; Triple Negative Breast Neoplasms | 2023 |
2 other study(ies) available for etoposide and apatinib
| Article | Year |
|---|---|
Apatinib and etoposide: surprising efficacy of an oral combination.
Topics: Etoposide; Female; Humans; Ovarian Neoplasms; Platinum; Prospective Studies; Pyridines | 2018 |
Successful treatment of radiotherapy and apatinib in patient with mediastinal mixed non-seminomatous germ cell tumor: A case report.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Pyridines; Radiotherapy, Intensity-Modulated; Testicular Neoplasms | 2021 |